Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit α members in breast cancer

被引:7
|
作者
Li, Mingjie [1 ]
Wang, Qianyun [1 ]
Zheng, Qinqin [2 ]
Wu, Lin [1 ]
Zhao, Bin [1 ]
Wu, Yan'an [1 ]
机构
[1] Xiamen Univ, Xiangan Hosp, Sch Med, Dept Clin Lab, Xiamen 361102, Peoples R China
[2] Xiamen Univ, Dept Clin Lab, Fuzhou Hosp 2, Fuzhou 350007, Peoples R China
关键词
breast cancer; KM plotter; P4HAs; prognosis; survival; SQUAMOUS-CELL CARCINOMA; MICROARRAY DATA; P4HA1; IDENTIFICATION; MUTATIONS; TOOL;
D O I
10.2217/bmm-2020-0323
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: We aimed to evaluate the diagnostic and prognostic values of P4HAs in breast cancer (BC) patients. Materials & methods: Kaplan-Meier plotter was used to evaluate the prognostic values of P4HAs and correlations between their expression and clinical characteristics were assessed based on The Cancer Genome Atlas and the Human Protein Atlas. Results: The current study showed that P4HAs were highly expressed in BC patients with clinical stage I compared with nontumor control and elevated P4HAs were correlated with poor survival outcomes. Subtypes analysis revealed that P4HA1 and P4HA2 were most expressed in HER2+ subtypes patients. Univariate analysis displayed that elevated P4HA1 and P4HA3 correlated with unfavorable recurrence-free survival in mutated TP53 patients. Conclusion: This study indicated the diagnostic and prognostic roles of P4HAs members and broadened the biomarker fields of early diagnosis and prognostic monitoring of BC patients.
引用
收藏
页码:1085 / 1096
页数:12
相关论文
共 50 条
  • [1] Prolyl 4-hydroxylase
    Gorres, Kelly L.
    Raines, Ronald T.
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 45 (02) : 106 - 124
  • [2] Cloning and expression analysis of the α-subunit of porcine prolyl 4-hydroxylase
    Cho, Eun Scok
    Jung, Won Yong
    Kwon, Eun Jung
    Park, Da Hye
    Chung, Ki Hwa
    Cho, Kwang Kenn
    Kim, Chul Wook
    ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES, 2007, 20 (11): : 1655 - 1661
  • [3] Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis
    Laitala, Anu
    Aro, Ellinoora
    Walkinshaw, Gail
    Maki, Joni M.
    Rossi, Maarit
    Heikkila, Minna
    Savolainen, Eeva-Riitta
    Arend, Michael
    Kivirikko, Kari I.
    Koivunen, Peppi
    Myllyharju, Johanna
    BLOOD, 2012, 120 (16) : 3336 - 3344
  • [4] STRUCTURE OF THE GENE OF THE BETA-SUBUNIT OF CHICKEN PROLYL 4-HYDROXYLASE
    NAKAZAWA, M
    AIDA, T
    EVERSON, WV
    GONDA, MA
    HUGHES, SS
    KAO, WWY
    COLLAGEN AND RELATED RESEARCH, 1988, 8 (06): : 529 - 529
  • [5] THE COMPLETE CDNA DERIVED SEQUENCE OF THE RAT PROLYL 4-HYDROXYLASE A SUBUNIT
    HOPKINSON, I
    SMITH, SA
    DONNE, A
    GREGORY, H
    FRANKLIN, TJ
    GRANT, ME
    ROSAMOND, J
    GENE, 1994, 149 (02) : 391 - 392
  • [6] PROTEIN HYDROXYLATION - PROLYL 4-HYDROXYLASE, AN ENZYME WITH 4 COSUBSTRATES AND A MULTIFUNCTIONAL SUBUNIT
    KIVIRIKKO, KI
    MYLLYLA, R
    PIHLAJANIEMI, T
    FASEB JOURNAL, 1989, 3 (05): : 1609 - 1617
  • [7] Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients
    Feng, Dechao
    Li, Li
    Li, Dengxiong
    Wu, Ruicheng
    Zhu, Weizhen
    Wang, Jie
    Ye, Luxia
    Han, Ping
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [8] Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients
    Dechao Feng
    Li Li
    Dengxiong Li
    Ruicheng Wu
    Weizhen Zhu
    Jie Wang
    Luxia Ye
    Ping Han
    European Journal of Medical Research, 28
  • [9] High Prolyl 4-Hydroxylase Subunit Alpha 3 Expression as an Independent Prognostic Biomarker and Correlated With Immune Infiltration in Gastric Cancer
    Niu, Xiaoji
    Ren, Liman
    Wang, Shoumei
    Gao, Dong
    Ma, Mingyue
    Hu, Aiyan
    Qi, Hongjun
    Zhang, Shuhui
    FRONTIERS IN GENETICS, 2022, 13
  • [10] NOVEL INHIBITORS OF PROLYL 4-HYDROXYLASE
    DOWELL, RI
    HADLEY, EM
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (05) : 800 - 804